Jeff Aronin is the CEO and founder of Ovation Pharmaceuticals LLC. He created the company in 2000 after feeling that there was a way he could treat those who had unmet goals. Jeff Aronin graduated from the Northern Illinois University with a degree and MBA. He then joined the healthcare industry before starting his own company.
One day he was treating a child, and the situation made him make a lifetime decision. He was undecided between using medicine or a complex surgery on the child. He, however, chose to give medication a try. In the process, he saved the child from the complex process of surgery and improved the child’s condition. This encounter helped improve his passion for his patients. His core belief and drive is to help people lead a better life. He has achieved this by commercializing medicines to meet the unmet needs of patients.
The focus he has on drug development and patients is what sets apart his company from the rest. Most of the companies in pharmaceutical space and biotech are less concerned with addressing minor diseases. In 2009, Lundbeck offered to buy Ovation. The company was sold for $900 million. Lundbeck kept Jeff Aronin as CEO to assist in the transition. Due to his massive contribution, the company continues to enjoy a successful spell.
Aronin is also a leading incubator and investor in biotech companies. Paragon is focused on bringing medication to the market by building companies and identifying unmet needs. Paragon has helped build companies such as Harmony Biosciences and Castle Creek Pharmaceuticals.
Harmony Biosciences deals with disorders that affect the central nervous system. Castle Creek deals with genetic dermatology conditions. These companies have continued to prosper with the hope that one day they will meet the needs of patients.
Jeff Aronin has supported the community in many ways. He has achieved this in partnership with Paragon Biosciences which shares the same vision. Jeff Aronin is a board member of the World Business Chicago that creates a partnership between private companies and the city to ensure growth. He was appointed to this position by Rahm Emanuel, the mayor of Chicago. He also serves as a member of the board of directors of Discover Financial Services. He has built a foundation that does research and patience advocacy for overlooked diseases.